Activating Transposon Mutagenesis for Bacterial Gene Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for engineering bacterial cells for biotechnological applications, such as protein production and bioremediation, face challenges in identifying and optimizing genes that are either disadvantageous or advantageous for specific conditions, making it difficult to create strains that are more efficient and tractable for these uses.
Innovation Solution
The use of activating transposons (TnA) for transposon mutagenesis allows for the identification and manipulation of genes that are advantageous or disadvantageous for growth conditions, enabling the creation of mutant bacteria with improved survival and growth by removing disadvantageous genes and overexpressing advantageous ones, through a process that can be iteratively refined.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional transposon mutagenesis is used to identify genes for biotechnological applications, then genes can be identified, but it cannot distinguish between advantageous and disadvantageous genes
Solution Approach 1:
The patent inverts the traditional transposon mutagenesis approach by using activating transposons that enhance gene expression instead of inactivating genes. This inversion allows the identification of advantageous genes that improve biotechnological applications, complementing the traditional method's identification of disadvantageous genes.
Solution Approach 2:
The patent creates a universal gene identification system that can identify both advantageous and disadvantageous genes using complementary approaches (traditional Tn-seq for disadvantageous genes and activating Tn-seq for advantageous genes), making the overall methodology applicable to a broader range of biotechnological optimization scenarios.
2Loss of energy
If the strip down approach is used to remove non-essential genes, then metabolic burden is reduced, but genes advantageous for biotechnological applications are not identified
Solution Approach 1:
The patent implements a feedback mechanism where activating transposon insertion patterns are analyzed to identify genes that, when overexpressed, improve biotechnological application performance. This feedback information guides subsequent genetic engineering decisions to enhance both metabolic efficiency and application-specific performance.
Solution Approach 2:
The patent performs preliminary identification of advantageous genes through activating Tn-seq before conducting the strip down process. This preliminary action ensures that genes beneficial for biotechnological applications are identified and preserved or enhanced, rather than inadvertently removed during genome minimization.
3Ease of manufacture
If natural bacterial strains are used directly, then no engineering is needed, but they are not optimized for biotechnological use
Solution Approach 1:
The patent performs preliminary identification of both disadvantageous and advantageous genes using complementary Tn-seq approaches before engineering the bacterial strain. This preliminary genetic characterization enables targeted optimization that improves biotechnological performance while avoiding unnecessary engineering of already-optimized pathways.
Solution Approach 2:
The patent enables precise parameter changes in bacterial strains by identifying specific genes to remove (disadvantageous) and specific genes to overexpress (advantageous). This targeted parameter modification approach optimizes biotechnological performance metrics such as productivity, yield, or stress tolerance without requiring comprehensive genome reengineering.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the engineering of bacteria that are better adapted to specific growth conditions and biotechnological applications, improving their survival and growth performance, and can be applied to various biotechnological uses such as bioremediation, biofuel production, and vaccine development.
Implementation Method 1
the TnA comprises a promoter capable of increasing transcription of a gene at or near its insertion site
Implementation Method 2
generating a pool of mutant bacteria by transposon mutagenesis with an activating transposon (TnA)
Data Source
Figure 1
Figure 2~3B
Figure 4A~4B
AI summary
Described is a process for producing a mutant bacterium which exhibits improved survival and/or growth under a selected growth condition, the process comprising the steps of: (a) generating a pool of mutant bacteria by transposon mutagenesis with an activating transposon (TnA), wherein the TnA comprises a promoter capable of increasing transcription of a gene at or near its insertion site; (b) growing bacteria from the mutant pool under the selected growth condition and under one or more reference conditions to produce two or more test cultures; and (c) comparing the distribution of TnA insertions between test cultures to identify a first class of genes which are disadvantageous for growth and/or survival under the selected growth condition and a second class of genes which are advantageous for growth and/or survival under the selected growth condition.